Koolen SLW - Search Results

1

Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition.

Buck SAJ, Van Hemelryk A, de Ridder C, Stuurman D, Erkens-Schulze S, van 't Geloof S, Teubel WJ, Koolen SLW, Martens-Uzunova ES, van Royen ME, de Wit R, Mathijssen RHJ, van Weerden WM. Buck SAJ, et al. Among authors: koolen slw. Mol Cancer Ther. 2024 May 2;23(5):711-720. doi: 10.1158/1535-7163.MCT-23-0420. Mol Cancer Ther. 2024. PMID: 38030379

2

Pharmacokinetics of gemcitabine and metabolites in a patient with double-sided nephrectomy: a case report and review of the literature.

Koolen SL, Huitema AD, Jansen RS, van Voorthuizen T, Beijnen JH, Smit WM, Schellens JH. Koolen SL, et al. Oncologist. 2009 Sep;14(9):944-8. doi: 10.1634/theoncologist.2009-0111. Epub 2009 Sep 2. Oncologist. 2009. PMID: 19726456 Free article. Review.

3

Pharmacokinetics of dalteparin during haemodialysis.

Nigten J, de Groot KA, Grootendorst DC, Koolen SL, Herruer MH, Schut NH. Nigten J, et al. Nephron Clin Pract. 2013;124(3-4):179-83. doi: 10.1159/000356384. Epub 2013 Dec 24. Nephron Clin Pract. 2013. PMID: 24401673

4

Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.

Moes J, Koolen S, Huitema A, Schellens J, Beijnen J, Nuijen B. Moes J, et al. Eur J Pharm Biopharm. 2013 Jan;83(1):87-94. doi: 10.1016/j.ejpb.2012.09.016. Epub 2012 Oct 17. Eur J Pharm Biopharm. 2013. PMID: 23085332 Clinical Trial.

5

Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001).

Moes JJ, Koolen SL, Huitema AD, Schellens JH, Beijnen JH, Nuijen B. Moes JJ, et al. Int J Pharm. 2011 Nov 28;420(2):244-50. doi: 10.1016/j.ijpharm.2011.08.041. Epub 2011 Sep 2. Int J Pharm. 2011. PMID: 21907780 Clinical Trial.

6

A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.

Kuip EJ, Zandvliet ML, Koolen SL, Mathijssen RH, van der Rijt CC. Kuip EJ, et al. Br J Clin Pharmacol. 2017 Feb;83(2):294-313. doi: 10.1111/bcp.13129. Epub 2016 Oct 29. Br J Clin Pharmacol. 2017. PMID: 27619152 Free PMC article. Review.

7

Individualized Tamoxifen Dose Escalation-Letter.

Koolen SL, Bins S, Mathijssen RH. Koolen SL, et al. Clin Cancer Res. 2016 Dec 15;22(24):6300. doi: 10.1158/1078-0432.CCR-16-1967. Clin Cancer Res. 2016. PMID: 27980024 No abstract available.

8

Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine-3ß-glucuronide and morphine-6ß-glucuronide in human plasma.

de Bruijn P, Kuip EJM, Lam MH, Mathijssen RHJ, Koolen SLW. de Bruijn P, et al. Among authors: koolen slw. J Pharm Biomed Anal. 2018 Feb 5;149:475-481. doi: 10.1016/j.jpba.2017.11.035. Epub 2017 Nov 17. J Pharm Biomed Anal. 2018. PMID: 29182997

9

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.

Bins S, Basak EA, El Bouazzaoui S, Koolen SLW, Oomen-de Hoop E, van der Leest CH, van der Veldt AAM, Sleijfer S, Debets R, van Schaik RHN, Aerts JGJV, Mathijssen RHJ. Bins S, et al. Among authors: koolen slw. Br J Cancer. 2018 May;118(10):1296-1301. doi: 10.1038/s41416-018-0074-1. Epub 2018 Apr 26. Br J Cancer. 2018. PMID: 29695768 Free PMC article.

10

Development of an Enzyme-Linked Immune Sorbent Assay to Measure Nivolumab and Pembrolizumab Serum Concentrations.

Basak EA, Wijkhuijs AJM, Mathijssen RHJ, Koolen SLW, Schreurs MWJ. Basak EA, et al. Among authors: koolen slw. Ther Drug Monit. 2018 Oct;40(5):596-601. doi: 10.1097/FTD.0000000000000534. Ther Drug Monit. 2018. PMID: 29847460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page